GRIN Therapeutics Unveils Breakthrough Clinical Trial Insights for Radiprodil at AES Annual Meeting GRIN Therapeutics is set to present innovative methodologies for assessing the Beeline clinical trial of radiprodil, focusing on GRIN-related disorders at the American Epilepsy Society Annual Meeting.

GRIN Therapeutics Unveils Breakthrough Clinical Trial Insights for Radiprodil at AES Annual Meeting #United_States #Atlanta #GRIN_Therapeutics #Radiprodil #Neurodevelopmental_Disorders

GRIN Therapeutics Unveils Significant Updates for Radiprodil at 2025 International Epilepsy Congress GRIN Therapeutics showcased crucial clinical developments for Radiprodil aimed at treating GRIN-related neurodevelopmental disorders at the 2025 ILAE Congress.

GRIN Therapeutics Unveils Significant Updates for Radiprodil at 2025 International Epilepsy Congress #USA #New_York #GRIN_Therapeutics #Radiprodil #Neurodevelopmental_Disorders